These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8615955)
21. Off-label uses of drugs and medical devices: should the FDA crack down? Margolis RE Healthspan; 1993 Jan; 10(1):18-9. PubMed ID: 10124289 [No Abstract] [Full Text] [Related]
22. The issue of extralabel drug use. Kennedy JA J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877 [No Abstract] [Full Text] [Related]
29. Qualitative research in dentistry. Stewart K; Gill P; Chadwick B; Treasure E Br Dent J; 2008 Mar; 204(5):235-9. PubMed ID: 18327186 [TBL] [Abstract][Full Text] [Related]
30. Premarket notifications of new dietary ingredients--a ten-year review. McGuffin M; Young AL Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394 [No Abstract] [Full Text] [Related]
31. Using research for clinical decision-making: the elements of a research report. McCann AL; Schneiderman ED J Contemp Dent Pract; 2002 Feb; 3(1):74-84. PubMed ID: 12167915 [No Abstract] [Full Text] [Related]
32. FDA embraces risk-management approach. Fox JL Nat Biotechnol; 2003 Oct; 21(10):1120-1. PubMed ID: 14520383 [No Abstract] [Full Text] [Related]
33. Drug review "behind the curtain": a response to Professor Struve. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971 [No Abstract] [Full Text] [Related]
34. FDA seeks to clear up confusion about compounding. J Am Vet Med Assoc; 2003 Oct; 223(8):1103, 1106. PubMed ID: 14584731 [No Abstract] [Full Text] [Related]
35. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids. Heymann LA Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670 [No Abstract] [Full Text] [Related]
36. The big gap at the FDA. Stipp D Fortune; 2002 Jul; 146(2):113-4, 116. PubMed ID: 12141178 [No Abstract] [Full Text] [Related]
37. New FDA guidance documents. Bradshaw ST Food Drug Law J; 2007; 62(2):429-31. PubMed ID: 17632971 [No Abstract] [Full Text] [Related]
38. EMEA approves OGS drug rejected by FDA. Mitchell P Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490 [No Abstract] [Full Text] [Related]